Patient info Open main menu

Ezetrol® 10 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: No longer supplied Details

Medicine strength:
10 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Ezetrol 10 mg tablets

1. WHAT EZETROL® IS AND WHAT IT IS USED FOR

Ezetrol® is a medicine to lower increased levels of cholesterol. Ezetrol® lowers levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood. In addition, Ezetrol® raises levels of “good” cholesterol (HDL cholesterol).

Ezetimibe, the active ingredient of Ezetrol®, works by reducing the cholesterol absorbed in your digestive tract.

Ezetrol® adds to the cholesterol lowering effect of statins, a group of medicines that reduce the cholesterol your body makes by itself.

Cholesterol is one of several fatty substances found in the bloodstream. Your total cholesterol is made up mainly of LDL and HDL cholesterol. LDL cholesterol is often called “bad” cholesterol because it can build up in the walls of your arteries forming plaque. Eventually this plaque build-up can lead to a narrowing of the arteries. This narrowing can slow or block blood flow to vital organs such as the heart and brain. This blocking of blood flow can result in a heart attack or stroke.

HDL cholesterol is often called “good” cholesterol because it helps keep the bad cholesterol from building up in the arteries and protects against heart disease.

Triglycerides are another form of fat in your blood that may increase your risk for heart disease.

It is used for patients who cannot control their cholesterol levels by cholesterol lowering diet alone. You should stay on your cholesterol lowering diet while taking this medicine.

Ezetrol® is used in addition to your cholesterol lowering diet if you have:

  • a raised cholesterol level in your blood (primary

    hypercholesterolaemia [heterozygous familial and non-familial])

    • together with a statin, when your cholesterol level is not well

      controlled with a statin alone

    • alone, when statin treatment is inappropriate or is not tolerated
  • a hereditary illness (homozygous familial hypercholesterolaemia) that

    increases the cholesterol level in your blood. You will also be prescribed a statin and may also receive other treatments.

  • a hereditary illness (homozygous sitosterolaemia, also known as

    phytosterolaemia) that increases the levels of plant sterols in your blood.

If you have heart disease, Ezetrol® combined with cholesterol lowering medicines called statins reduces the risk of heart attack, stroke, surgery to increase heart blood flow, or hospitalisation for chest pain. Ezetrol® does not help you lose weight.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE EZETROL®

If you use Ezetrol® together with a statin, please read the package leaflet of that particular medicine.

Do not take Ezetrol® if:

  • you are allergic (hypersensitive) to ezetimibe or any of the other

    ingredients of this medicine (see section 6: Contents of the pack and other information).

    Do not take Ezetrol® together with a statin if:

    • you currently have liver problems.
    • you are pregnant or breast-feeding.

Warnings and precautions

Talk to your doctor or pharmacist before taking Ezetrol®.

  • Tell your doctor about all your medical conditions including allergies.
  • Your doctor should do a blood test before you start taking Ezetrol® with a statin. This is to check how well your liver is working.
  • Your doctor may also want you to have blood tests to check how well your liver is working after you start taking Ezetrol® with a statin. If you have moderate or severe liver problems, Ezetrol® is not recommended.

The safety and efficacy of the combined use of Ezetrol® and certain cholesterol lowering medicines, the fibrates have not been established.

Children and adolescents

Do not give this medicine to children and adolescents (6 to 17 years of age) unless prescribed by a specialist because there are limited data on safety and efficacy.

Do not give this medicine to children less than 6 years old because there is no information in this age group.

Other medicines and Ezetrol®

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. In particular, tell your doctor if you are taking medicine(s) with any of the following active ingredients:

  • ciclosporin (often used in organ transplant patients)
  • medicines with an active ingredient to prevent blood clots, such as warfarin, phenprocoumon, acenocoumarol or fluindione (anticoagulants)
  • colestyramine (also used to lower cholesterol), because it affects the way Ezetrol® works
  • fibrates (also used to lower cholesterol)

Pregnancy and breast-feeding

Do not take Ezetrol® with a statin if you are pregnant, are trying to get pregnant or think you may be pregnant. If you get pregnant while taking Ezetrol® with a statin, stop taking both medicines immediately and tell your doctor.

There is no experience from the use of Ezetrol® without a statin during pregnancy. Ask your doctor for advice before using Ezetrol® if you are pregnant.

Do not take Ezetrol® with a statin if you are breast-feeding, because it is not known if the medicines are passed into breast milk. Ezetrol® without a statin should not be used if you are breast-feeding. Ask your doctor for advice.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Ezetrol® is not expected to interfere with your ability to drive or to use machinery. However, it should be taken into account that some people may get dizzy after taking Ezetrol®.

Ezetrol® contains lactose

Ezetrol® tablets contain a sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Ezetrol® contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially sodium-free.

3. HOW TO TAKE EZETROL®

Always take this medicine exactly as your doctor has told you. Continue taking your other cholesterol lowering medicines unless your doctor tells you to stop.

You should check with your doctor or pharmacist if you are not sure.

  • Before starting Ezetrol®, you should be on a diet to lower your cholesterol.
  • You should keep on this cholesterol lowering diet whilst taking

    Ezetrol®.

The recommended dose is one Ezetrol® 10 mg Tablet by mouth once a day.

Take Ezetrol® at any time of the day. You can take it with or without food. If your doctor has prescribed Ezetrol® along with a statin, both medicines can be taken at the same time. In this case, please read the dosage instructions in the package leaflet of that particular medicine. If your doctor has prescribed Ezetrol® along with another medicine for lowering cholesterol containing the active ingredient colestyramine or any other medicine containing bile acid sequestrant, you should take Ezetrol® at least 2 hours before or 4 hours after taking the bile acid sequestrant.

If you take more Ezetrol® than you should

Please contact your doctor or pharmacist.

If you forget to take Ezetrol®

Do not take a double dose to make up for a forgotten tablet, just take your normal amount of Ezetrol® at the usual time the next day.

If you stop taking Ezetrol®

Talk to your doctor or pharmacist because your cholesterol may rise again.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following terms are used to describe how often side effects have been reported:

  • Very common (may affect more than 1 of 10 patients)
  • Common (may affect up to 1 of 10 patients)
  • Uncommon (may affect up to 1 of 100 patients)
  • Rare (may affect up to 1 of 1,000 patients)
  • Very rare (may affect up to 1 of 10,000 patients, including isolated

    reports).

Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness. This is because on rare occasions, muscle problems, including muscle breakdown resulting in kidney damage, can be serious and may become a potentially life-threatening condition.

Allergic reactions, including swelling of the face, lips, tongue, and/or throat that may cause difficulty in breathing or swallowing (which requires treatment right away) have been reported in general use. When used alone, the following side effects were reported: Common: abdominal pain; diarrhoea; flatulence; feeling tired. Uncommon: elevations in some laboratory blood tests of liver (transaminases) or muscle (CK) function; cough; indigestion; heartburn; nausea; joint pain; muscle spasms; neck pain; decreased appetite, pain, chest pain, hot flush; high blood pressure.

Additionally, when used with a statin, the following side effects were reported:

Common: elevations in some laboratory blood tests of liver function (transaminases); headache; muscle pain, tenderness or weakness. Uncommon: tingling sensation; dry mouth; itching; rash; hives; back pain; muscle weakness; pain in arms and legs; unusual tiredness or weakness; swelling, especially in the hands and feet.

When used with fenofibrate, the following common side effect was reported: abdominal pain.

Additionally, the following side effects have been reported in general use: dizziness; muscle aches; liver problems; allergic reactions including rash and hives; raised red rash, sometimes with target-shaped lesions (erythema multiforme); muscle pain, tenderness or weakness; muscle breakdown; gallstones or inflammation of the gallbladder (which may cause abdominal pain, nausea, vomiting); inflammation of the pancreas often with severe abdominal pain; constipation, reduction in blood cell counts, which may cause bruising/bleeding (thrombocytopaenia); tingling sensation; depression: unusual tiredness or weakness; shortness of breath.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE EZETROL®

  • Keep out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.
  • Do not store above 30°C.
  • Store in the original package in order to protect from moisture.
  • If the tablets become discoloured or show any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Ezetrol® contains

The active substance is ezetimibe. Each tablet contains 10 mg ezetimibe. The other ingredients are: lactose monohydrate, microcrystalline cellulose, povidone, croscarmellose sodium, sodium laurilsulfate, magnesium stearate.

What Ezetrol® looks like and contents of the pack

Ezetrol® tablets are white to off-white, capsule-shaped tablets with code “414” on one side.

Pack size: 30 tablets in push-through blisters.

Manufactured by Organon Heist bv, Industriepark 30, 2220 Heist-op-den-Berg, Belgium.

Procured from within the EU and repackaged by the Product Licence Holder Beachcourse Ltd., Unit 2-3, Townsend Industrial Estate, Waxlow Road, London, NW10 7NU.

Revision date: 22.04.2025

PL 16378/1270 POM

Ezetrol® is a registered trademark of N.V. Organon

Blind or partially sighted?

Is this leaflet hard to see or read? Phone Beachcourse,

Tel: 020 8896 9054 for help. Ref. number: 1270/V1

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 16378/1270

Last revision stated in the text: 22 April 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Ezetrol 10 mg tablets

Active substance Ezetimibe
Strength 10 mg
Pharmaceutical form Oral tablet
White to off-white, capsule-shaped tablets, approximately 2.60 mm thick, debossed with ‘414’ on one side.
How is it taken Oral
Excipients Croscarmellose sodium, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Povidone (K29-32), Sodium laurilsulfate
Is it available? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage Do not store above 30°C.
Blisters: Store in the original package in order to protect from moisture. Bottles: Keep the bottle tightly closed in order to protect from moisture.
Drug group (ATC) Other lipid modifying agents
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AX Other lipid modifying agents
          1. C10AX09 ezetimibe
Marketing authorisation PL 00025/0609 (first authorised 3 April 2003), PLPI 16378/1270
Marketing authorisation holder Organon Pharma (UK) Limited
Codes BNF 02120000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.